IQVIA Holdings | IQV - Assets


IQVIA Holdings reported $29.68B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Accenture USD 68.81B 1.74B Mar/2026
Agilent USD 13.07B 252M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Cardinal Health USD 56.69B 1.39B Mar/2026
Celltrion KRW 768.81B 9.37B Mar/2026
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Cigna USD 153.27B 4.65B Mar/2026
Cognizant Technology Solutions USD 20.5B 192M Mar/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
CVS Health USD 252.97B 564M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Elevance Health USD 126.44B 611M Jun/2026
Humana USD 55.28B 6.37B Mar/2026
IBM USD 156.23B 4.35B Mar/2026
Illumina USD 6.56B 85M Mar/2026
Infosys INR 1.43T 169.96B Dec/2025
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Laboratory Of America USD 19.09B 694.4M Mar/2026
Malin Corporation EUR 198.5M 70.1M Dec/2024
McKesson USD 82.32B 1.87B Mar/2026
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Organigram Holdings CAD 521.31M 9.36M Mar/2026
Ovoca Bio EUR 1.66M 9.75M Jun/2025
Pharma Mar EUR 385.26M 9.82M Mar/2026
Publicis EUR 40.14B 128M Jun/2026
Qiagen NV USD 6.3B 257.54M Dec/2025
Quest Diagnostics USD 16.67B 448M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Sartorius EUR 9.87B 154.9M Mar/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Tilray USD 2.1B 15.95M Sep/2025
Trubridge Inc USD 402.53M 3.12M Dec/2025
UnitedHealth USD 309.73B 2.92B Jun/2026
Veeva Systems USD 9.13B 150.22M Mar/2026
Veradigm USD 1.5B 185.94M Dec/2022
Waters USD 24.53B 19.45B Mar/2026
Zealand Pharma A/S 15.95B 848.45M Dec/2025
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026